Vaxxinity Inc (NASDAQ: VAXX) closed the day trading at $0.68 down -14.89% from the previous closing price of $0.80. In other words, the price has decreased by -$0.1184 from its previous closing price. On the day, 783456 shares were traded.
Ratios:
For a better understanding of VAXX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.15 and its Current Ratio is at 2.15. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.51.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on September 08, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 08 ’23 when Prime Movers Lab Fund I LP sold 25,089 shares for $1.67 per share. The transaction valued at 41,899 led to the insider holds 8,713,663 shares of the business.
Prime Movers Lab Fund I LP sold 22,872 shares of VAXX for $38,196 on Sep 08 ’23. The 10% Owner now owns 831,658 shares after completing the transaction at $1.67 per share. On Sep 07 ’23, another insider, Prime Movers Lab Fund I LP, who serves as the 10% Owner of the company, sold 20,312 shares for $1.79 each. As a result, the insider received 36,302 and left with 8,738,752 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VAXX now has a Market Capitalization of 85.76M and an Enterprise Value of 56.55M. Its current Enterprise Value per Revenue stands at -199.98k whereas that against EBITDA is -0.90.
Stock Price History:
Over the past 52 weeks, VAXX has reached a high of $3.10, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is 0.7448, while the 200-Day Moving Average is calculated to be 1.4631.
Shares Statistics:
Over the past 3-months, VAXX traded about 398.05K shares per day on average, while over the past 10 days, VAXX traded about 639.62k shares per day. A total of 112.18M shares are outstanding, with a floating share count of 45.25M. Insiders hold about 64.30% of the company’s shares, while institutions hold 9.95% stake in the company. Shares short for VAXX as of Feb 15, 2024 were 3.81M with a Short Ratio of 9.58, compared to 3.48M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.01% and a Short% of Float of 8.90%.
Earnings Estimates
Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.1 and a low estimate of -$0.1, while EPS last year was -$0.16. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.46 and -$0.46 for the fiscal current year, implying an average EPS of -$0.46. EPS for the following year is -$0.38, with 1 analysts recommending between -$0.38 and -$0.38.
